Volcano Corporation Schedules Third Quarter Conference Call, Webcast

Tuesday, November 6, 2007 General News J E 4
SAN DIEGO, Nov. 5 Volcano Corporation(Nasdaq: VOLC) today announced that it will report its operating results forthe third quarter and first nine months of fiscal 2007 on Thursday, November 8.

The company will hold a conference call to discuss its financial resultsand operating activities open to all interested parties at 2 p.m., PacificStandard Time (5 p.m. Eastern Standard Time), Thursday, November 8, hosted byScott Huennekens, president and chief executive officer, and John Dahldorf,chief financial officer.

The teleconference can be accessed by calling (719) 325-4887, passcode2329894. Please dial in 10-15 minutes prior to the beginning of the call. Thewebcast will be available through the company's website at

A replay of the conference call will be available through Thursday,November 15, at (719) 457-0820, passcode 2329894 and via the company's website.

About Volcano Corporation

Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devicesdesigned to facilitate endovascular procedures, enhance the diagnosis ofvascular and structural heart diseases and guide optimal therapies. Thecompany's intravascular ultrasound (IVUS) product line includes ultrasoundconsoles that can be integrated directly into virtually any modern cath lab.Volcano IVUS also offers unique features, including both single-use phasedarray and rotational IVUS imaging catheters, and advanced functionalityoptions, such as VH(TM) IVUS tissue characterization and ChromaFlo(R). Volcanoalso provides functional measurement (FM) consoles and single-use pressure andflow guide wires. Currently, more than 2,700 Volcano IVUS and FM systems areinstalled worldwide, with approximately half of its revenues coming fromoutside the United States. For more information, visit the company's websiteat

SOURCE Volcano Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Vermillion Announces U.S. Patent Office Re-Issues ...
Keryx Biopharmaceuticals, Inc. Announces Positive ...